Product lifecycle solutions
We deliver intelligent insights through the pharmaceutical product lifecycle
From early-stage commercial opportunity assessment and market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and post-launch tracking, we can support pharma with intelligent market research and consulting solutions through the lifecycle of the brand.
Senior level involvement
Our large, senior team of over 40 Directors are involved at every stage of the project.
High quality research
Our outputs answer the key business questions with a clear, direct recommendation, supported by the research evidence.
Communication and flexibility
We keep clients informed through weekly updates and respond quickly to needs and deadlines.
A creative approach
We offer custom approaches, not branded solutions, so our research design is always creative and fresh.
- Some example case studiesHow we helped determine the next groundbreaking development in a hard-to-treat respiratory disease
The challengeOur client wanted to understand the current management in a complex therapy area, as treatment regimens require a combination of multiple drugs. Furthermore, the disease is most prevalent in emerging, hard-to-access markets. Understanding of drugs and treatment regimen preferences were required to help gauge likely success of the client’s new formulation in development, which would be part of a new regimen paradigm. As well…read more »How we used WhatsApp and projective exercises to capture deep emotional insights into people living with HIV in South Africa
The challengeOur client wanted to identify and profile different segments of people living with HIV in order to understand key barriers and leverage points and ensure future engagement with their pharmaceutical portfolio. To achieve this, we needed to conduct an in-depth exploration of attitudes and behaviours of people living with HIV. However, stigma surrounding HIV in South Africa meant that respondents may have been unwilling…read more »How we helped our client maximise uptake and fine-tune the marketing strategy for their vaccine product in China
The challenge:Our client’s vaccine to protect against a condition prevalent in older adults had recently launched and secondary research was required to enable them to understand more about their target healthcare consumer and attitudes to health, well-being and vaccination. They needed to build a complete picture of how consumers are influenced, such as whether they are more influenced by HCP advice or online forums and…read more »
- Our latest white papersChina: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »Are dual ARVs the new frontier in a maturing HIV market?
Tackling and managing HIV has been one of the pharmaceutical industry’s more distinguished achievements, despite the turbulence and antagonism that marked the early days of AIDS-related R&D and the industry’s relationships with governments, patients and activists.read more »